Literature DB >> 22040385

Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles.

Géraldine Le Duc1, Imen Miladi, Christophe Alric, Pierre Mowat, Elke Bräuer-Krisch, Audrey Bouchet, Enam Khalil, Claire Billotey, Marc Janier, François Lux, Thierry Epicier, Pascal Perriat, Stéphane Roux, Olivier Tillement.   

Abstract

Ultrasmall gadolinium-based nanoparticles (GBNs) induce both a positive contrast for magnetic resonance imaging and a radiosentizing effect. The exploitation of these characteristics leads to a greater increase in lifespan of rats bearing brain tumors since the radiosensitizing effect of GBNs can be activated by X-ray microbeams when the gadolinium content is, at the same time, sufficiently high in the tumor and low in the surrounding healthy tissue. GBNs exhibit therefore an interesting potential for image-guided radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040385     DOI: 10.1021/nn202797h

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  51 in total

1.  Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance-Computed Tomography Image Guided Radiation Therapy.

Authors:  Alexandre Detappe; Eloise Thomas; Mark W Tibbitt; Sijumon Kunjachan; Oksana Zavidij; Nishita Parnandi; Elizaveta Reznichenko; François Lux; Olivier Tillement; Ross Berbeco
Journal:  Nano Lett       Date:  2017-02-02       Impact factor: 11.189

2.  Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI.

Authors:  Andrea Bianchi; Sandrine Dufort; François Lux; Arnaud Courtois; Olivier Tillement; Jean-Luc Coll; Yannick Crémillieux
Journal:  MAGMA       Date:  2013-10-30       Impact factor: 2.310

3.  In vivo and ex vivo applications of gold nanoparticles for biomedical SERS imagingi.

Authors:  Mehmet V Yigit; Zdravka Medarova
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

4.  Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.

Authors:  Audrey Bouchet; Marie Bidart; Imen Miladi; Céline Le Clec'h; Raphaël Serduc; Charles Coutton; Pierrick Regnard; Enam Khalil; Sandrine Dufort; Benjamin Lemasson; Jean Laissue; Laurent Pelletier; Géraldine Le Duc
Journal:  Tumour Biol       Date:  2014-03-16

5.  Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.

Authors:  Lova Sun; Daniel Y Joh; Ajlan Al-Zaki; Melissa Stangl; Surya Murty; James J Davis; Brian C Baumann; Michelle Alonso-Basanta; Gary D Kaol; Andrew Tsourkas; Jay F Dorsey
Journal:  J Biomed Nanotechnol       Date:  2016-02       Impact factor: 4.099

6.  Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents.

Authors:  Andrea Bianchi; Sandrine Dufort; François Lux; Pierre-Yves Fortin; Nawal Tassali; Olivier Tillement; Jean-Luc Coll; Yannick Crémillieux
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

7.  Multiparametric investigation of non functionalized-AGuIX nanoparticles in 3D human airway epithelium models demonstrates preferential targeting of tumor cells.

Authors:  Lucie Sancey; Odile Sabido; Zhiguo He; Fabien Rossetti; Alain Guignandon; Valérie Bin; Jean-Luc Coll; Michèle Cottier; François Lux; Olivier Tillement; Samuel Constant; Christophe Mas; Delphine Boudard
Journal:  J Nanobiotechnology       Date:  2020-09-10       Impact factor: 10.435

Review 8.  Nanomedicine in chemoradiation.

Authors:  Seth M Miller; Andrew Z Wang
Journal:  Ther Deliv       Date:  2013-02

Review 9.  Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Dalong Ni; Wenbo Bu; Emily B Ehlerding; Weibo Cai; Jianlin Shi
Journal:  Chem Soc Rev       Date:  2017-11-27       Impact factor: 54.564

10.  Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases.

Authors:  M Howell; C Wang; A Mahmoud; G Hellermann; S S Mohapatra; S Mohapatra
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.